Table 1 Characteristics of primary care physicians by country

Participation

 Targeted physicians

1450

98

1224

128

 Respondents

511 (35.2%)

62 (63.3%)

343 (28.0%)

106 (82.8%)

Type of physicians (m.d.=0)

 General Practitioners

491 (96.1%)

62 (100%)

343 (100%)

86 (81.1%)

 Pediatricians

20 (3.9%)

0

0

20 (18.9%)

Sex (m.d.=2)

 Female

217 (42.6%)

26 (41.9%)

131 (38.2%)

60 (57.7%)

<10⁻²

 Male

292 (57.4%)

36 (58.1%)

212 (61.8%)

44 (42.3%)

Age (years) (m.d.=9)

 25-39

106 (21.1%)

3 (4.8%)

100 (29.9%)

3 (2.9%)

<10⁻⁵

 40-54

114 (22.7%)

9 (14.5%)

84 (25.1%)

21 (20%)

 ≥ 55

282 (56.2%)

50 (80.6%)

151 (45.1%)

81 (77.1%)

 Median (IQR)

56 (42; 62)

61 (56; 65)

52 (37; 60)

60 (55; 62)

<10⁻⁵

Practice area (m.d.=3)

 Rural

149 (29.3%)

22 (35.5%)

79 (23%)

48 (46.6%)

<10⁻⁴

 Urban

359 (70.7%)

40 (64.5%)

264 (77%)

55 (53.4%)

Physicians’ anxiety (m.d.=7)

 Low anxiety feeling

176 (34.9%)

24 (38.7%)

140 (41.3%)

12 (11.7%)

<10⁻⁵

 Moderate anxiety feeling

246 (48.8%)

28 (45.2%)

164 (48.4%)

54 (52.4%)

 High anxiety feeling

82 (16.3%)

10 (16.1%)

35 (10.3%)

37 (35.9%)

 Median (IQR)

4 (2; 6)

3 (2; 6)

3 (2; 5)

6 (4; 7)

<10⁻⁵

Patients’ anxiety (m.d.=4)

 Low anxiety feeling

107 (21.1%)

13 (21%)

73 (21.3%)

21 (20.4%)

0.85

 Moderate anxiety feeling

286 (56.4%)

38 (61.3%)

188 (55%)

60 (58.3%)

 High anxiety feeling

114 (22.5%)

11 (17.7%)

81 (23.7%)

22 (21.4%)

 Median (IQR)

4 (3; 6)

5 (3; 6)

5 (3; 6)

4 (3; 6)

0.89

Risk of seeing infected patients in the next 2 weeks (m.d.=3)

 Low risk

400 (78.7%)

46 (74.2%)

295 (86%)

59 (57.3%)

<10⁻⁵

 Moderate risk

97 (19.1%)

15 (24.2%)

46 (13.4%)

36 (35%)

 High risk

11 (2.2%)

1 (1.6%)

2 (0.6%)

8 (7.8%)

 Median (IQR)

1 (0; 2)

1 (1; 3)

1 (0; 2)

2 (1; 5)

<10⁻⁵

Finding the measures taken by the health authorities suitable to limit the spread of COVID-19 (m.d.=3)

409 (80.5%)

51 (82.3%)

275 (80.2%)

83 (80.6%)

0.93

Changes in professional practices (m.d.=4)

207 (40.8%)

30 (48.4%)

124 (36.3%)

53 (51.5%)

<10⁻²

Impact on consultations (m.d.=3)

72 (14.2%)

8 (12.9%)

39 (11.4%)

25 (24.3%)

<10⁻²

  Types of consequences (m.d.=5)

  Questions about any links with China during consultations

44 (61.1%)

4 (50%)

19 (48.7%)

21 (84%)

  Increased consultation time due to question about COVID-19

22 (30.6%)

1 (12.5%)

14 (35.9%)

7 (28%)

  Specific consultations for information on COVID-19

6 (8.3%)

0

1 (2.6%)

5 (20%)

  Phone calls on COVID-19

6 (8.3%)

2 (25%)

3 (7.7%)

1 (4%)

  Consultations of patients who thought they had contracted COVID-19

6 (8.3%)

1 (12.5%)

4 (10.3%)

1 (4%)

Anticipation of the epidemic arrival (m.d.=3)

337 (66.3%)

40 (64.5%)

200 (58.3%)

97 (94.2%)

<10⁻⁵

  Types of anticipation measures (m.d. =32)

  Search of guidelines

205 (60.8%)

33 (82.5%)

113 (56.5%)

59 (60.8%)

  Purchase of protection equipment

122 (36.2%)

4 (10%)

63 (31.5%)

55 (56.7%)

  Re-use of the influenza pandemic kits

106 (35.7%)

N.A.

80 (40%)

26 (26.8%)

  Office reorganization to avoid patients’ influx

60 (17.8%)

9 (22.5%)

34 (17%)

17 (17.5%)

  Other measures

13 (3.9%)

1 (2.5%)

9 (4.5%)

3 (3.1%)

Level of information regarding the epidemic (m.d.=9)

 Low information level

80 (16.3%)

6 (9.6%)

59 (17.5%)

15 (14.6%)

0.05

 Moderate information level

168 (33.5%)

14 (22.6%)

120 (35.6%)

34 (33,0%)

 High information level

254 (50.6%)

42 (67.7%)

158 (46.9%)

54 (52.4%)

Feeling prepared to face the epidemic (m.d.=4)

229 (45.2%)

28 (45.2%)

139 (40.6%)

62 (60.2%)

<10⁻²